<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pediatric Crohn disease activity index (PCDAI)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pediatric Crohn disease activity index (PCDAI)</h1>
<div class="graphic"><div class="figure"><div class="ttl">Pediatric Crohn disease activity index (PCDAI)</div><div class="cntnt"><table cellspacing="0"><colgroup width="70%"></colgroup><colgroup width="30%"></colgroup> <tbody> <tr> <td class="subtitle1" colspan="2">History (recall, 1 week)</td> </tr> <tr> <td class="subtitle2_left">Abdominal pain</td> <td> </td> </tr> <tr> <td class="indent1">None</td> <td>____(0)</td> </tr> <tr> <td class="indent1">Mild – Brief, does not interfere with activities</td> <td>____(5)</td> </tr> <tr class="divider_bottom"> <td class="indent1">Moderate or severe – Daily, longer lasting, affects activities, nocturnal</td> <td>____(10)</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Stools (per day)</td> </tr> <tr> <td class="indent1">0 to 1 liquid stools, no blood</td> <td>____(0)</td> </tr> <tr> <td class="indent1">Up to 2 semi-formed stools with small blood, or 2 to 5 liquid stools without blood</td> <td>____(5)</td> </tr> <tr class="divider_bottom"> <td class="indent1">Gross bleeding, or ≥6 liquid stools, or nocturnal diarrhea</td> <td>____(10)</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Patient functioning, general well-being (recall, 1 week)</td> </tr> <tr> <td class="indent1">No limitations of activities, well</td> <td>____(0)</td> </tr> <tr> <td class="indent1">Occasional difficulty in maintaining age-appropriate activities, below par</td> <td>____(5)</td> </tr> <tr> <td class="indent1">Frequent limitation of activity, very poor</td> <td>____(10)</td> </tr> <tr> <td class="subtitle1" colspan="2">Laboratory</td> </tr> <tr> <td class="subtitle2_left" colspan="2">HCT (%)</td> </tr> <tr> <td class="subtitle3_left" colspan="2">&lt;10 years</td> </tr> <tr> <td class="indent2">&gt;33</td> <td>____(0)</td> </tr> <tr> <td class="indent2">28 to 32</td> <td>____(2.5)</td> </tr> <tr> <td class="indent2">&lt;28</td> <td>____(5)</td> </tr> <tr> <td class="subtitle3_left" colspan="2">11 to 19 years (females)</td> </tr> <tr> <td class="indent2">≥34</td> <td>____(0)</td> </tr> <tr> <td class="indent2">29 to 33</td> <td>____(2.5)</td> </tr> <tr> <td class="indent2">&lt;29</td> <td>____(5)</td> </tr> <tr> <td class="subtitle3_left" colspan="2">11 to 14 years (males)</td> </tr> <tr> <td class="indent2">≥35</td> <td>____(0)</td> </tr> <tr> <td class="indent2">30 to 34</td> <td>____(2.5)</td> </tr> <tr> <td class="indent2">&lt;30</td> <td>____(5)</td> </tr> <tr> <td class="subtitle3_left" colspan="2">15 to 19 years (males)</td> </tr> <tr> <td class="indent2">≥37</td> <td>____(0)</td> </tr> <tr> <td class="indent2">32 to 36</td> <td>____(2.5)</td> </tr> <tr class="divider_bottom"> <td class="indent2">&lt;32</td> <td>____(5)</td> </tr> <tr> <td class="subtitle2_left" colspan="2">ESR (mm/hour)</td> </tr> <tr> <td class="indent1">&lt;20</td> <td>____(0)</td> </tr> <tr> <td class="indent1">20 to 50</td> <td>____(2.5)</td> </tr> <tr class="divider_bottom"> <td class="indent1">&gt;50</td> <td>____(5)</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Albumin (g/dL)</td> </tr> <tr> <td class="indent1">≥3.5</td> <td>____(0)</td> </tr> <tr> <td class="indent1">3.1 to 3.4</td> <td>____(5)</td> </tr> <tr> <td class="indent1">≤3</td> <td>____(10)</td> </tr> <tr> <td class="subtitle1" colspan="2">Examination</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Weight</td> </tr> <tr> <td class="indent1">Weight gain, weight stable, or voluntary weight loss</td> <td>____(0)</td> </tr> <tr> <td class="indent1">Involuntary weight stable, or weight loss 1 to 9%</td> <td>____(5)</td> </tr> <tr class="divider_bottom"> <td class="indent1">Weight loss ≥10%</td> <td>____(0)</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Height</td> </tr> <tr> <td class="subtitle3_left" colspan="2">At diagnosis</td> </tr> <tr> <td class="indent2">&lt;1 channel decrease*</td> <td>____(0)</td> </tr> <tr> <td class="indent2">1 to 2 channel decrease</td> <td>____(5)</td> </tr> <tr> <td class="indent2">≥2 channel decrease</td> <td>____(10)</td> </tr> <tr> <td class="indent2" colspan="2"><strong>or</strong></td> </tr> <tr> <td class="subtitle3_left" colspan="2">Follow-up<sup>¶</sup></td> </tr> <tr> <td class="indent2">High velocity ≥-1 SD</td> <td>____(0)</td> </tr> <tr> <td class="indent2">High velocity between -1 and -2 SD</td> <td>____(5)</td> </tr> <tr class="divider_bottom"> <td class="indent2">High velocity ≤-2 SD</td> <td>____(10)</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Abdomen</td> </tr> <tr> <td class="indent1">No tenderness, no mass</td> <td>____(0)</td> </tr> <tr> <td class="indent1">Tenderness, or mass without tenderness</td> <td>____(5)</td> </tr> <tr class="divider_bottom"> <td class="indent1">Tenderness, involuntary guarding, definite mass</td> <td>____(10)</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Perirectal disease</td> </tr> <tr> <td class="indent1">None, asymptomatic tags</td> <td>____(0)</td> </tr> <tr> <td class="indent1">1 to 2 indolent fistula(e), scant drainage, no tenderness</td> <td>____(5)</td> </tr> <tr class="divider_bottom"> <td class="indent1">Active fistula, drainage, tenderness, or abscess</td> <td>____(10)</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Extraintestinal manifestations</td> </tr> <tr> <td class="indent1" colspan="2">(Fever ≥38.5°C for 3 days over past week, definite arthritis, uveitis, erythema nodosum, pyoderma gangrenosum)</td> </tr> <tr> <td class="indent1">None</td> <td>____(0)</td> </tr> <tr> <td class="indent1">1</td> <td>____(5)</td> </tr> <tr> <td class="indent1">≥2</td> <td>____(10)</td> </tr> <tr> <td class="subtitle1_left">Total score</td> <td class="subtitle1_left">________</td> </tr> </tbody></table></div><div class="graphic_lgnd">The PCDAI is interpreted as follows: a score of 0 to 10 indicates inactive disease, 11 to 30 indicates mild disease activity, and &gt;30 indicates moderate to severe disease activity. A decrease in PCDAI of ≥12.5 points reflects a clinical response (improvement from moderate/severe to mild/inactive disease)<sup innerhtml="">[1]</sup>.<br/><sup innerhtml=""><br/></sup>A weighted version of the PCDAI (wPCDAI) has also been developed (not shown here), with a maximum score of 125<sup innerhtml="">[2]</sup>. For the wPCDAI, a score of &lt;12.5 indicates remission, 12.5 to 40 indicates mild disease activity, 40 to 57.5 indicates moderate disease activity, and &gt;57.5 indicates severe disease activity.</div><div class="graphic_footnotes">PCDAI: pediatric Crohn disease activity index; HCT: hematocrit; ESR: erythrocyte sedimentation rate; SD: standard deviation.<br/>* A "channel decrease" refers to serial height measurements that deviate across the width of a major curve on a standard height-for-age chart. For example, decreasing from the 40<sup>th</sup> to 20<sup>th</sup> percentile is a 1-channel decrease. <br/>¶ Height velocity is measured against population standards, eg, Tanner JM, Davies S. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985; 107:317.</div><div class="graphic_reference">References: <br/><ol>
<li>Hyams J, Markowitz J, Otley A, et al. Evaluation of the pediatric Crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr 2005; 41:416.</li>
<li>Turner D, Griffiths AM, Walters TD, et al. Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis 2012; 18:55.</li></ol>Table from: Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991; 12:439. Reproduced with permission from Lippincott Williams &amp; Wilkins. Copyright © 1991 ESPGHAN and NASPGHAN. Unauthorized reproduction of this material is prohibited.</div><div id="graphicVersion">Graphic 100489 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
